[go: up one dir, main page]

TN2010000611A1 - Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer - Google Patents

Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer

Info

Publication number
TN2010000611A1
TN2010000611A1 TNP2010000611A TN2010000611A TN2010000611A1 TN 2010000611 A1 TN2010000611 A1 TN 2010000611A1 TN P2010000611 A TNP2010000611 A TN P2010000611A TN 2010000611 A TN2010000611 A TN 2010000611A TN 2010000611 A1 TN2010000611 A1 TN 2010000611A1
Authority
TN
Tunisia
Prior art keywords
cancer
treatment
combination
aminoheteroaryl compound
met antagonist
Prior art date
Application number
TNP2010000611A
Other languages
English (en)
Inventor
Liliane Goetsch
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/058709 external-priority patent/WO2010003992A1/fr
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2010000611A1 publication Critical patent/TN2010000611A1/fr

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TNP2010000611A 2009-07-08 2010-12-27 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer TN2010000611A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/058709 WO2010003992A1 (fr) 2008-07-08 2009-07-08 Combinaison d'un antagoniste de c-met et d'un composé aminohétéroaryle pour le traitement d'un cancer

Publications (1)

Publication Number Publication Date
TN2010000611A1 true TN2010000611A1 (en) 2012-05-24

Family

ID=55024683

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000611A TN2010000611A1 (en) 2009-07-08 2010-12-27 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer

Country Status (1)

Country Link
TN (1) TN2010000611A1 (fr)

Similar Documents

Publication Publication Date Title
MX2011000255A (es) Combinacion de un antagonista a c-met y un compuesto aminoheteroarilo, para el tratamiento de cancer.
WO2011099832A3 (fr) Nouveau composé de benzimidazole, son procédé de préparation et composition pharmaceutique le contenant
GB201118656D0 (en) New compounds
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
PH12012502399A1 (en) Combination therapy methods for treating proliferative diseases
AU2010233994A8 (en) Bispecific anti-ErbB-3/anti-c-Met antibodies
MY160456A (en) Benzodiazepine bromodomain inhibitor
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
PL2532364T3 (pl) Kompozycja farmaceutyczna zawierająca przeciwciała anty CAPRIN-1 do leczenia i/lub zapobiegania nowotworowi
MY158560A (en) Composition comprising antiboby that binds to domain ii of her2 and acidic variants thereof
MX349004B (es) Nuevos compuestos.
WO2014062720A3 (fr) Méthodes de traitement du cancer
MX366899B (es) Nuevos compuestos.
MY204500A (en) Dosing regimen associated with long acting injectable paliperidone esters
IN2012DN02018A (fr)
WO2011127333A3 (fr) Composés pour le traitement d'une maladie, pour l'administration, et pour des compositions pharmaceutiques
MX347893B (es) Conjugados de farmaco y anticuerpo humano contra factor de tejido.
MX350200B (es) Anticuerpos humanos y conjugados de anticuerpo-farmaco contra cd74.
MX2013007455A (es) Anticuerpos anti-cd38.
MX2019000225A (es) Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades.
PH12014502406A1 (en) Anti-il-23p19 antibodies
WO2012032209A3 (fr) Composition pharmaceutique pour le traitement de l'oeil sec
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
WO2010121164A3 (fr) Composés de 1,4-benzodiazépinone et leur utilisation dans le traitement du cancer